Skip to main content

Table 2 Genetic loci associated with smoking behaviour in the Lung Health Study

From: The genetics of smoking in individuals with chronic obstructive pulmonary disease

Phenotype

SNP

Chr

Gene(s)

Position (hg19)

Alleles (REF/ALT)

MAF

Imputation r2

beta

SE

P value

% Variance

Cotinine

rs10023464

4

UGT2B10

69,659,738

C/T

9.8%

0.995

0.25

0.04

1.27e-11

1.1%

Cotinine

rs9788721

15

CHRNA3/5

78,802,869

C/T

39.5%

0.989

−0.12

0.02

3.49e-7

0.6%

eCO

rs546764

3

CEP70

138,294,336

T/G

2.8%

0.844

0.39

0.07

7.76e-8

0.9%

eCO

rs140706189

14

SIX1/4/6, MNAT1

61,151,425

T/G

1.7%

0.827

−0.49

0.09

6.31e-8

0.9%

eCO

rs12914385

15

CHRNA3/5

78,898,723

C/T

43%

1.000

0.12

0.02

2.38e-8

1.2%

CPD

rs1412076

9

NTNG2/ SETX

135,032,890

A/G

37.6%

0.999

0.10

0.02

2.24e-7

0.8%

CPD

rs9599114

13

PCDH9

66,987,131

T/C

41.7%

0.957

0.11

0.02

7.94e-8

0.8%

Cessation

rs212420

7

ATXN7L1/ CDHR3

105,496,412

C/G

6.7%

0.992

−0.60

0.11

1.50e-7

n/a

Cessation

rs207675

10

KCNMA1

79,154,537

T/C

33.6%

0..988

−0.35

0.06

5.95e-8

n/a

  1. UGT2B10 UDP glucuronosyltransferase family 2 member B10, CHRNA3 cholinergic receptor nicotinic alpha 3 subunit, CHRNA5 cholinergic receptor nicotinic alpha 5 subunit, CEP70 centrosomal protein 70, SIX1 SIX homeobox 1, MNAT1 MNAT1, CDK activating kinase assembly factor, NTNG2 Nitrin G2, SETX senataxin, PCDH9 protocadherin 9, ATXN7L1 ataxin 7 like 1, CDHR3 cadherin related family member 3, KCNMA1 potassium calcium-activated channel subfamily M alpha 1, * Refers to odds ratio and 95% confidence intervals (CI)